Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Zymeworks (ZYME) Shares Issued (2021 - 2025)

Zymeworks' Shares Issued history spans 5 years, with the latest figure at -$10.1 million for Q4 2025.

  • On a quarterly basis, Shares Issued fell 213.8% to -$10.1 million in Q4 2025 year-over-year; TTM through Sep 2025 was $18.9 million, a 2359.22% increase, with the full-year FY2024 number at $8.9 million, up 76.93% from a year prior.
  • Shares Issued hit -$10.1 million in Q4 2025 for Zymeworks, down from $7.9 million in the prior quarter.
  • Over the last five years, Shares Issued for ZYME hit a ceiling of $107.5 million in Q2 2022 and a floor of -$107.4 million in Q3 2022.
  • Historically, Shares Issued has averaged $6.8 million across 5 years, with a median of $1.3 million in 2023.
  • Biggest five-year swings in Shares Issued: skyrocketed 12533.33% in 2023 and later crashed 316.4% in 2024.
  • Tracing ZYME's Shares Issued over 5 years: stood at -$5.4 million in 2021, then surged by 2076.05% to $107.4 million in 2022, then crashed by 99.28% to $770000.0 in 2023, then soared by 1050.26% to $8.9 million in 2024, then tumbled by 213.8% to -$10.1 million in 2025.
  • Business Quant data shows Shares Issued for ZYME at -$10.1 million in Q4 2025, $7.9 million in Q3 2025, and $1.4 million in Q2 2025.